Journal of Molecular Biomarkers & Diagnosis

6^th International Conference on Biomarkers & Clinical Research

August 31-September 02, 2015 Toronto, Canada

Scientific Tracks Abstracts

• DNA methylation biomarkers for lung cancer: From tissue based discovery to cell free DNA methylation testing

  Martin Weber, Matthias Wielscher, Christa Noehammer, Elisabeth Reithuber, Walter Pulverer, Klemens Vierlinger, Andrea Gsur, Rolf Ziesche and Andreas Weinhaeusel

  PDF HTML

• Mining the human urinary proteome biomarker discovery for human cancer and its metastases

  Marsha A Moses1,2

  PDF HTML

• The road from discovery to therapy through the use of antibodies

  Jan Voskuil

  PDF HTML

• Applying systems biology and predictive genomic analytics on patients with lung squamous cell carcinoma and RNA-Seq gene expression

  Scott Marshall

  PDF HTML

• Prediction of local recurrence in ductal carcinoma in situ: Clinical validation of DCIS score

  Sharon Nofech Mozes

  PDF HTML

• Virus identification: Development of methods in the post-PCR antiviral therapy

  Biswendu B Goswami

  PDF HTML

• Cardiac biomarkers: Troponins

  N S Neki

  PDF HTML

• PPPM as a model of healthcare services to operate biomarkers of newer generations to monitor clinical and subclinical stages of chronic inflammatory conditions of autoimmune origin

  Sergey Suchkov

  PDF HTML

• Post-infectious autoimmune syndrome (PIFAS) as a predictive and a diagnostic factor to monitor chronic diseases of infectious and autoimmune origin (CDIO)

  Trevor G Marshall

  PDF HTML

• Viral myocarditis as a model to clearly demonstrate the impact and role of the human endomicrobiota changes into the development of chronic autoimmune diseases

  Mandrik Mark1,2

  PDF HTML

• Autoimmunity and autoimmune disorders-genomics and genome-based applications to set up biobanks networks and to secure genetic passportization

  Borovikov Artem1,2

  PDF HTML

• Application of bioinformatics in autoimmune disorders for identifying druggable pathways and promising targets

  Irina Zhegalova1,2

  PDF HTML

• Systemic autoimmune disorders: SLE and RA as an illustration of the clinical and predictive value of DNA-abzymes as unique biomarkers of newer generation to monitor the disorders at subclinical and clinical stages and to

  Alisa Petkevich

  PDF HTML

• Organ-specific autoimmune disorders: Translational biomarkers to confirm the diagnosis and to predict chronification and disabling

  Dmitrii Cherepahin

  PDF HTML

• Tissue-specific autoimmune disorders: Antibody-proteases as a generation of highly informative and unique biomarkers to monitor subclinical and clinical stages of demyelination in multiple sclerosis (MS)

  Sergey Suchkov

  PDF HTML

• Osteoarthritis unmasked: Identification of nuclear prohibitin as a new specific OA biomarker and therapeutic target

  Alain Moreau

  PDF HTML

• Developing a blood metabolite HMT biomarker for Major Depression Disorder (MDD)

  Alexander M Buko

  PDF HTML

• Proteomic strategies to overcome tumor resistance to oncology targeted medicines

  Chee Gee See

  PDF HTML

• Cell cycle and the world of biomarkers: What can we learn from proteomic studies?

  Iulia M Lazar

  PDF HTML

• Differential mass-spectrometry proteomic and bioinformatic analysis of Leishmania donovani treated with miltefosine and analogs

  Maria Paola Costi1, Stefania Ferrari1, Julia Eick2, Eugenia Bifeld2, Joachim Clos2, Pantelis Afroudakis3, Kyriakos C Prousis3, Theodora Calogeropoulou3, Anabela Cordeiro da Silva4, Nuno Santarem4, Catarina Baptista4, Leda Severi1 and Filippo Genovese1

  PDF HTML

• Implication of cancer proteomics in development of biomarkers for early detection of HCC

  S K Jain1, Shabnam Malik1, Maryam Ranjpour1 and Deepshikha Pande-Katare2

  PDF HTML

• A chemical approach to mine the immunoproteome for disease biomarkers

  Todd M Doran

  PDF HTML

• Biomarkers in early phase oncology clinical development

  Sid Katugampola

  PDF HTML

• Identification of a protein panel as pharmacodynamic biomarker of folate directed targeted drugs in the treatment of ovarian cancer

  Maria Paola Costi, Laura Taddia, Leda Severi, Domenico D’Arca, Glauco Ponterini, Filippo Genovese and Diego Pinetti

  PDF HTML

• Algorithm for evaluation of the tumor markers for diagnostics and therapy monitoring in cancer diseases

  Judita Kinkorova, O Topolcan, O Fiala, M Karlikova, S Svobodova, R Kucera, R Fuchsova and V Treska

  PDF HTML

• Are urinary biomarkers from clinical studies biomarkers of disease or biomarkers of medicine?

  Youhe Gao

  PDF HTML

• Immunochemical detection of glycated lens crystallins and their circulating auto-antibodies in human serum during aging

  Mala Ranjan, Sujatha Nayak, Tanuja K and Sashidhar R B

  PDF HTML

• Clinical biomarkers in drug development: Quantitative PCR-based fit-for-purpose assay qualification

  Shashwati Basak

  PDF HTML

• Development of a novel IHC based test for prediction of risk of recurrence for breast cancer patients

  Manjiri Bakre

  PDF HTML

• Sao Paulo workers exposed to air pollution: Evaluation of genotoxicity

  Mônica Valeria Marquezini

  PDF HTML

• Dermcidin is a novel biomarker of hepatic carcinoma?

  Fanghua Qiu

  PDF HTML

• Development of regulatory biomarkers for identification of metallic allergens and non-allergens

  Ying Mu1 and Chris Donahue2

  PDF HTML

• Saving urinary proteins and nucleic acids on a piece of membrane simply and economically

  Youhe Gao1,2 and Fanshuang Zhang2

  PDF HTML

• Predictive molecular diagnosis of Alzheimer’s dementia: Towards new clinical models for preventive treatment

  Jens Wiltfang

  PDF HTML

• A comprehensive approach for blood-derived biomarker assessment in pulmonary hypertension

  Vasile Foris1,2, Gabor Kovacs1,2, Philipp Douschan1,2, Horst Olschewski1,2, Andrea Olschewski1,3, Bahil Ghanim2, Walter Klepetko3 and Alexander Avian3

  PDF HTML

• Diagnostic implications of altered miRNA profiles in esophageal cancer

  Rinu Sharma

  PDF HTML

• The usage of biomarkers in terms of biological exposure indices for health surveillance in Thailand

  Nalinee Sripaung

  PDF HTML

• Clinical significance of cytogenetic biomarkers in acute myeloid leukemia: An Indian experience

  Pina J Trivedi

  PDF HTML

• Carotid arteries plaques regression in heterozygous familial hypercholesterolemia patients on statin therapy

  Samia Perwaiz Khan

  PDF HTML

• A comprehensive pipeline for biomarker discovery using circulating miRNA microarray data

  Landoni E1,2, Miceli R2, Callari M2, Tiberio P2, Appierto V2, Angeloni V2, Mariani L2 and Daidone M G2

  PDF HTML

• Mammalian hair follicles: Insights into microRNAs as a traumatic brain injury (TBI) biomarker

  Jing Zhang1, Rosalinda Knight2, Tyson Josey3, Yushan Wang3, Thomas W Sawyer3, Christopher J Martyniuk2,4 and Valerie S Langlois1

  PDF HTML

• Efficacy of TSHR mRNA as a tumor marker in the follow-up of differentiated thyroid cancer

  Surasawadee Ausavarat, Jiraporn Sriprapaporn, Aunchalee Laipiriyakun, Busara Satayaban, Boontham Amornkitticharoen, Rujaporn Chanachai and Chaveewan Pattanachak

  PDF HTML

• Application of clinical exome sequencing and semantic knowledge base approach identifies potential causative variants in a family pedigree with atypical autosomal dominant distal muscular dystrophy

  Mahjoubeh Jalali Sefid Dashti1, Henning F2, Jeanine Heckmann1 and Junaid Gamieldien1

  PDF HTML

• Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemo-resistance and poor outcome in AML

  Sewa Rijal

  PDF HTML